Healthcare provider profile · identity verified

Gregory Morales, MD

Internal Medicine · LOS ANGELES, CA · NPI 1891866836

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	850	295
Losartan Potassium	Losartan Potassium	414	146
Amlodipine Besylate	Amlodipine Besylate	356	128
Lisinopril	Lisinopril	289	96
Metformin Hcl	Metformin Hcl	250	89
Levothyroxine Sodium	Levothyroxine Sodium	221	76
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	218	73
Simvastatin	Simvastatin	195	63
Omeprazole	Omeprazole	187	76
Glipizide	Glipizide	162	55
Tamsulosin Hcl	Tamsulosin Hcl	159	54
Rosuvastatin Calcium	Rosuvastatin Calcium	156	59
Metformin Hcl Er	Metformin Hcl	150	57
Alendronate Sodium	Alendronate Sodium	135	45
Atenolol	Atenolol	127	46
Hydrochlorothiazide	Hydrochlorothiazide	121	40
Gabapentin	Gabapentin	113	44
Trazodone Hcl	Trazodone Hcl	102	33
Metoprolol Tartrate	Metoprolol Tartrate	99	34
Pradaxa	Dabigatran Etexilate Mesylate	93	23
Terazosin Hcl	Terazosin Hcl	74	24
Bisoprolol Fumarate	Bisoprolol Fumarate	61	18
Furosemide	Furosemide	61	23
Potassium Chloride	Potassium Chloride	59	20
Finasteride	Finasteride	58	14
Jardiance	Empagliflozin	54	19
Triamcinolone Acetonide	Triamcinolone Acetonide	49	17
Ciclopirox	Ciclopirox	46	24
Albuterol Sulfate Hfa	Albuterol Sulfate	43	20
Pantoprazole Sodium	Pantoprazole Sodium	43	21
Allopurinol	Allopurinol	42	15
Hydralazine Hcl	Hydralazine Hcl	41	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	18
Carvedilol	Carvedilol	38	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	36	14
Spironolactone	Spironolactone	35	11
Eliquis	Apixaban	33	11
Naproxen	Naproxen	33	22
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	33	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Famotidine	Famotidine	29	suppressed
Acyclovir	Acyclovir	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Ozempic	Semaglutide	25	suppressed
Prednisone	Prednisone	25	19
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	24	24
Tramadol Hcl	Tramadol Hcl	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Humulin N	Insulin Nph Human Isophane	22	suppressed
Metoprolol Succinate	Metoprolol Succinate	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	19
Nitroglycerin	Nitroglycerin	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Meloxicam	Meloxicam	20	11
Mirtazapine	Mirtazapine	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Cephalexin	Cephalexin	18	17
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Amoxicillin	Amoxicillin	14	11
Glipizide Er	Glipizide	14	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	14	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	13	13
Alvesco	Ciclesonide	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Lactulose	Lactulose	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Nadolol	Nadolol	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error